LINC AT VIVA: LATEST TECHNIQUES & PIONEERING APPROACHES FOR CLTI INTERVENTIONS

Moderator(s)

• 

  Sahil Parikh, MD

  Director, Endovascular Services
  New York Presbyterian/Columbia University Irving Medical Center
  Interventional Cardiology
  New York, New York, United States

  Disclosure(s): Abbott Vascular: Advisory Board; Grants/Research Support Recipient; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
  Acotec: Grants/Research Support Recipient
  AVS: Grants/Research Support Recipient
  Boston Scientific: Advisory Board; Consultant; Grants/Research Support Recipient
  Cagent: Grants/Research Support Recipient
  Concept Medical: Advisory Board; Grants/Research Support Recipient
  Cordis: Advisory Board
  Inari Medical: Advisory Board
  Medinol: Grants/Research Support Recipient
  Medtronic: Advisory Board
  Penumbra: Advisory Board; Grants/Research Support Recipient
  Philips: Advisory Board; Grants/Research Support Recipient
  R3 Vascular: Advisory Board; Grants/Research Support Recipient
  Reflow: Grants/Research Support Recipient
  Reflow Medical: Grants/Research Support Recipient
  Shockwave: Advisory Board; Grants/Research Support Recipient; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
  Terumo: Consultant
  Veryan: Grants/Research Support Recipient
• 

  Thomas Zeller, MD

  Head Physician Department of Angiology
  Universitaets-Herzzentrum Freiburg - Bad Krozingen
  Bad Krozingen, Germany

  Disclosure(s): Acotec, Ablative Solutions, BD Bard Peripheral Vascular, Boston Scientific, Contego Medical, Cook Medical, Cordis, CSI, Gore & Associates, iVascular, MedAlliance, Medtronic, Micro Medical, R3 Vascular, Recor Medical, Reflow Medical, Reva Medical, Sho: Grants/Research Support Recipient
  Acotec, BD Bard, Biotronik, Boston Scientific Corp., Cook Medical, Cordis, Medtronic, Veryan: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
  ANT: Stockholder - Publicly-traded company (excludes mutual/index funds)
  Boston Scientific Corp., Gore & Associates, Medtronic, Shockwave, VentureMed, Veryan, Reflow Medical: Consultant

Panel(s)

• 

  Marianne Brodmann, MD

  Head of Division of Angiology
  Medical University Graz
  Angiology
  Graz, Austria

  Disclosure(s): Abbott Vascular: Advisory Board
  AngioDynamics: Advisory Board
  Biotronik: Advisory Board
  Boston Scientific: Advisory Board
  Cook Medical: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
  Cordis: Advisory Board
  Medtronic: Advisory Board
  Reflow: Advisory Board
  Shockwave: Advisory Board
• 

  Brian DeRubertis, MD

  Chief, Division of Vascular Surgery
  NewYork-Presbyterian / Weill Cornell Medical Center
  Vascular Surgery
  New York, New York, United States

  Disclosure(s): Abbott Vascular: Advisory Board; Consultant; Grants/Research Support Recipient; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
  BD (formerly Bard): Advisory Board; Consultant
  Boston Scientific: Advisory Board; Consultant; Grants/Research Support Recipient
  Cagent: Grants/Research Support Recipient; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
  Concept Medical: Advisory Board; Consultant; Grants/Research Support Recipient; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
  Medtronic: Advisory Board; Consultant; Speaker/Honoraria (includes speakers bureau, symposia, and expert witness)
• 

  Peter Schneider, MD

  Professor of Surgery
  University of California San Francisco
  Vascular Surgery
  San Francisco, California, United States

  Disclosure(s): Abbott: Consultant
  Acotec: Consultant
  BD (formerly Bard): Consultant
  Boston Scientific: Consultant
  Cagent: Consultant
  Endologix: Consultant
  Healthcare Inroads: Consultant
  Medtronic: Consultant
  Shockwave: Consultant
  Stryker: Consultant
  Surmodics: Consultant
• 

  Tim Wittig, MD

  Senior physician
  Division of Angiology, Department of Internal Medicine, University Hospital Leipzig, Leipzig, Germany
  Leipzig, Sachsen, Germany

  Disclosure(s): Philips: Consultant

Presentations:

• 3:55pm - 4:02pm PT

  CO2-Guided Revascularization in Complex CLTI Cases: When and How?
  

  Speaker: Tim Wittig, MD – Division of Angiology, Department of Internal Medicine, University Hospital Leipzig, Leipzig, Germany
• 4:02pm - 4:05pm PT

  Panel Discussion
• 4:05pm - 4:12pm PT

  Choosing the Right Interventional Strategy for Revascularization in CLTI: What Is the Evidence?
  

  Speaker: Peter A. Schneider, MD – University of California San Francisco
• 4:12pm - 4:15pm PT

  Panel Discussion
• 4:15pm - 4:22pm PT

  Vessel Preparation in BTK Procedures: Relevance and Differential Usage of Available Technologies
  

  Speaker: Marianne Brodmann, MD – Medical University Graz
• 4:22pm - 4:25pm PT

  Panel Discussion
• 4:25pm - 4:32pm PT

  Drug-Eluting Solutions for BTK Interventions: Ongoing Trials and Future Outlook
  

  Speaker: Thomas Zeller, MD – Universitaets-Herzzentrum Freiburg - Bad Krozingen
• 4:32pm - 4:35pm PT

  Panel Discussion
• 4:35pm - 4:42pm PT

  The Implementation of BVS Into Clinical Routine: How Far Have We Come?
  

  Speaker: Brian DeRubertis, MD – NewYork-Presbyterian / Weill Cornell Medical Center
• 4:42pm - 4:45pm PT

  Panel Discussion